Teledyne LABS’ new ReaXus reciprocating pump delivers supercritical CO₂ for SFE and SFC
July 12, 2024
Teledyne LABS' new class of reciprocating pumps delivers liquid CO2 for use in supercritical fluid extraction (SFE), supercritical fluid chromatography (SFC), and other applications. The new pump, designated “SC Class" by the company, joins the full range of Teledyne LABS' ReaXus reciprocating pumps as industry leaders for reliable, accurate and consistent operation. The ReaXus SC [...]
MGI Tech Launches DNBSEQ-G400RS FluoXpert in the APAC Region at Medlab Asia & Asia Health 2024
July 12, 2024
BANGKOK -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today launched DNBSEQ-G400RS FluoXpert in the APAC region and opened early access to the platform at Medlab Asia & Asia Health 2024. Integrating high-throughput sequencing and multiplex immunofluorescence (mIF) staining, DNBSEQ-G400RS FluoXpert challenges conventions [...]
NanoTemper Technologies Establishes Advisory Board to Propel Innovation and Growth
July 12, 2024
Munich, Germany – NanoTemper Technologies is proud to announce a significant milestone in its journey toward excellence and innovation in the biotech industry. The company has established an advisory board consisting of five distinguished professionals, each a seasoned expert in their respective fields. This move underscores NanoTemper Technologies’ commitment to fostering cutting-edge development while staying [...]
BrightSpec Appoints Damien Fischer as Global VP of Sales and Tim Germann as Independent Director
July 11, 2024
BrightSpec, the market leader in Molecular Rotational Resonance (MRR) spectroscopy solutions, announced today the appointment of two new executives to drive the commercialization of their growing portfolio of precision instruments and analytical tools. BrightSpec develops and commercializes instruments that harness the power of MRR spectroscopy, an innovative approach to rapidly and definitively characterize the unique [...]
July 11, 2024
myeloMATCH Precision Medicine Clinical Trial Leverages Next-Day Genomic Testing to Quickly Match Patients with Appropriate Trials Across North America WALTHAM, Mass. -- To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is partnering with the National [...]
July 11, 2024
Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. Integrated AI and microscopy expected to lead to better understanding of tumor structures and treatment strategies. New technology will work to capture and analyze the highly heterogeneous tumor microenvironment. WASHINGTON -- Danaher Corporation (NYSE: DHR), a global science and [...]
Parse Biosciences Launches Certified Service Provider Program
July 11, 2024
Eurofins Clinical Enterprise, LLC and SeqMatic first providers to join program, expanding access to Parse’s growing single cell portfolio SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of its Certified Service Provider (CSP) Program. For researchers who are seeking paths to outsource their single [...]
Mission Bio Appoints Roman Haehn as Chief Commercial Officer to Drive Market Expansion
July 11, 2024
Former Agena Bioscience EVP and GM to lead Mission Bio’s marketing, sales, and customer support efforts SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the appointment of Roman Haehn as Chief Commercial Officer. Drawing on more than 25 years of experience in diagnostics and life sciences [...]
MGI Tech and Predica Diagnostics Team Up for Precision RNA Sequencing in Oncology
July 11, 2024
Nijmegen, Netherlands - MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced the collaboration with Predica Diagnostics, a leading innovator in oncology diagnostics, to develop Predica’s targeted RNA sequencing tests on the cost-effective MGI Next-generation [...]
July 11, 2024
BugSeq, an innovative biotech company that provides a user-friendly and rapid bioinformatics platform for clinical and public health laboratories, announces it has entered a public-private partnership with the Biomedical Advanced Research and Development Authority's (BARDA) Division of Research, Innovation, and Ventures (DRIVe) to develop an artificial intelligence (AI)-powered reporting tool for clinical metagenomics data. BARDA is [...]

